There is a demand for safe and potent anti-obesity drugs, because currently available anti-obesity drugs, such asorlistat (gastrointestinal lipase inhibitor) and fibrates (PPARα agonists), cause undesirable side effects. The gene discussed is PPARA; the disease is Obesity.